Home » Newsletters » BioWorld Science

BioWorld Science

May 19, 2021

View Archived Issues

Kiromic submits IND to the FDA for phase I study of KB-PD1

ImmunityBio receives FDA authorization for phase I study of its m-ceNK platform

Clover reports preclinical data on second-generation protein-based COVID-19 vaccine candidate

China's NMPA approves phase I trial of InnoCare's TYK2 inhibitor ICP-332

T-cell modulation elicits long-term arthritis remission

Results reported from the first-in-human trial of CHF-6366 in healthy male volunteers

Gain-of-function SYK mutations are involved in immune dysregulation and systemic inflammation

Taysha Gene Therapies develops treatments for SURF1-related Leigh syndrome, SLC13A5 deficiency

Positive initial 12-week expression and safety data reported from ENDEAVOR study of SRP-9001

First patient dosed in phase I/II MAA-202 study of MarzAA

Enrollment begins in investigator-initiated study of D2C7-IT plus 2141-V11 in recurrent glioma

Genfleet begins phase I study of GFH-009 in hematologic malignancies

Ascentawits Pharmaceuticals patents AKR1C3-targeting drugs

Anti-BAFF therapy eradicates factor VIII inhibitors in hemophilia A

Medshine Discovery discloses xanthine oxidase inhibitors

Amgen synthesizes GTPase KRAS mutant inhibitors

Inhibition of CAMK1D restores sensitivity in PD-L1 refractory tumors

Eccogene (Shanghai) identifies SSAO inhibitors

Applied Genetic Technologies patents new AAV vectors

NADI-351 shows significant antitumor activity and low toxicity in xenograft models

CoVac-1, a COVID-19 vaccine useful for cancer patients undergoing B-cell depleting therapy

Veru advances VERU-111 into phase III for treatment of COVID-19

Phase I data on SLN-124 support ongoing evaluation in patients with thalassemia and MDS

JCR initiates phase II trial of JR-142 in pediatric patients with growth hormone deficiency

Life Science Institute reports findings from clinical study of CL-2020 in cerebral infarction

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026